Alimta

... Bloomberg.com: Top Worldwide Updated: New York: Dec 09 11:00London: Dec 09 16:00Tokyo: Dec 10 01:00 US AUBZFPGRHKIMJPLNSMIND : Top Worldwide Top Worldwide Regions Markets Economy/Politics Commentary Sports Culture RESOURCES: Bloomberg TV Bloomberg Radio Markets Top Worldwide E-Mail This Story Printer-Friendly Format Consumer Confidence in U.S.

Rises a Second Month as Gasoline Prices Ease Treasuries Drop, Wiping Out Week's Gains After Consumer Confidence Rises Listen Alltel to Spin Off Fixed-Line Unit in $9.1 Billion Transaction With Valor Listen Lilly Sees 2006 Earnings Rising 63 Percent From 2005 (Update4) Dec.

9 (Bloomberg) - Eli Lilly & Co., maker of the top- selling schizophrenia drug Zyprexa, forecast that 2006 earnings per share will rise 63 percent on expanding sales of its newest products.

Lilly shares jumped the most since April.

Net income next year will increase to $3.10 to $3.20 a share from the $1.90 to $1.96 projected for this year, Indianapolis- based Lilly said today in a statement before meeting with investors in New York.

Earnings in 2004 were $1.81 billion, or $1.66 a share.

Under Chief Executive Officer Sidney Taurel, Lilly has beaten earnings estimates at least six quarters in a row.

Taurel and executives are briefing investors on his plans to increase sales of Lilly's newest drugs.

Demand for the cancer treatment Read more...